Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Non-Alcoholic Steatohepatitis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Perspective (2018-2033)
2.2 Non-Alcoholic Steatohepatitis Treatment Growth Trends by Region
2.2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Non-Alcoholic Steatohepatitis Treatment Market Dynamics
2.3.1 Non-Alcoholic Steatohepatitis Treatment Industry Trends
2.3.2 Non-Alcoholic Steatohepatitis Treatment Market Drivers
2.3.3 Non-Alcoholic Steatohepatitis Treatment Market Challenges
2.3.4 Non-Alcoholic Steatohepatitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Alcoholic Steatohepatitis Treatment Players by Revenue
3.1.1 Global Top Non-Alcoholic Steatohepatitis Treatment Players by Revenue (2018-2023)
3.1.2 Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Non-Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Alcoholic Steatohepatitis Treatment Revenue
3.4 Global Non-Alcoholic Steatohepatitis Treatment Market Concentration Ratio
3.4.1 Global Non-Alcoholic Steatohepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis Treatment Revenue in 2022
3.5 Non-Alcoholic Steatohepatitis Treatment Key Players Head office and Area Served
3.6 Key Players Non-Alcoholic Steatohepatitis Treatment Product Solution and Service
3.7 Date of Enter into Non-Alcoholic Steatohepatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Alcoholic Steatohepatitis Treatment Breakdown Data by Type
4.1 Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2033)
5 Non-Alcoholic Steatohepatitis Treatment Breakdown Data by Application
5.1 Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Non-Alcoholic Steatohepatitis Treatment Market Size (2018-2033)
6.2 North America Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
6.4 North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Alcoholic Steatohepatitis Treatment Market Size (2018-2033)
7.2 Europe Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
7.4 Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size (2018-2033)
9.2 Latin America Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
9.4 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences Inc.
11.1.1 Gilead Sciences Inc. Company Detail
11.1.2 Gilead Sciences Inc. Business Overview
11.1.3 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.1.4 Gilead Sciences Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.1.5 Gilead Sciences Inc. Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Introduction
11.2.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Novo Nordisk A/S
11.3.1 Novo Nordisk A/S Company Detail
11.3.2 Novo Nordisk A/S Business Overview
11.3.3 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Introduction
11.3.4 Novo Nordisk A/S Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.3.5 Novo Nordisk A/S Recent Development
11.4 NGM Biopharmaceuticals
11.4.1 NGM Biopharmaceuticals Company Detail
11.4.2 NGM Biopharmaceuticals Business Overview
11.4.3 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction
11.4.4 NGM Biopharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.4.5 NGM Biopharmaceuticals Recent Development
11.5 Galectin Therapeutics Inc.
11.5.1 Galectin Therapeutics Inc. Company Detail
11.5.2 Galectin Therapeutics Inc. Business Overview
11.5.3 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.5.4 Galectin Therapeutics Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.5.5 Galectin Therapeutics Inc. Recent Development
11.6 Inventiva Pharma
11.6.1 Inventiva Pharma Company Detail
11.6.2 Inventiva Pharma Business Overview
11.6.3 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Introduction
11.6.4 Inventiva Pharma Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.6.5 Inventiva Pharma Recent Development
11.7 Intercept Pharmaceuticals
11.7.1 Intercept Pharmaceuticals Company Detail
11.7.2 Intercept Pharmaceuticals Business Overview
11.7.3 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction
11.7.4 Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.7.5 Intercept Pharmaceuticals Recent Development
11.8 AbbVie Inc.
11.8.1 AbbVie Inc. Company Detail
11.8.2 AbbVie Inc. Business Overview
11.8.3 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Introduction
11.8.4 AbbVie Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.8.5 AbbVie Inc. Recent Development
11.9 Madrigal Pharmaceuticals
11.9.1 Madrigal Pharmaceuticals Company Detail
11.9.2 Madrigal Pharmaceuticals Business Overview
11.9.3 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction
11.9.4 Madrigal Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.9.5 Madrigal Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2018-2023)
Table 8. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2024-2033)
Table 10. Non-Alcoholic Steatohepatitis Treatment Market Trends
Table 11. Non-Alcoholic Steatohepatitis Treatment Market Drivers
Table 12. Non-Alcoholic Steatohepatitis Treatment Market Challenges
Table 13. Non-Alcoholic Steatohepatitis Treatment Market Restraints
Table 14. Global Non-Alcoholic Steatohepatitis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Non-Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Treatment as of 2022)
Table 17. Ranking of Global Top Non-Alcoholic Steatohepatitis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-Alcoholic Steatohepatitis Treatment Product Solution and Service
Table 21. Date of Enter into Non-Alcoholic Steatohepatitis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Gilead Sciences Inc. Company Detail
Table 47. Gilead Sciences Inc. Business Overview
Table 48. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 49. Gilead Sciences Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 50. Gilead Sciences Inc. Recent Development
Table 51. Bristol Myers Squibb Company Detail
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Product
Table 54. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Novo Nordisk A/S Company Detail
Table 57. Novo Nordisk A/S Business Overview
Table 58. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Product
Table 59. Novo Nordisk A/S Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 60. Novo Nordisk A/S Recent Development
Table 61. NGM Biopharmaceuticals Company Detail
Table 62. NGM Biopharmaceuticals Business Overview
Table 63. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product
Table 64. NGM Biopharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 65. NGM Biopharmaceuticals Recent Development
Table 66. Galectin Therapeutics Inc. Company Detail
Table 67. Galectin Therapeutics Inc. Business Overview
Table 68. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 69. Galectin Therapeutics Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 70. Galectin Therapeutics Inc. Recent Development
Table 71. Inventiva Pharma Company Detail
Table 72. Inventiva Pharma Business Overview
Table 73. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Product
Table 74. Inventiva Pharma Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 75. Inventiva Pharma Recent Development
Table 76. Intercept Pharmaceuticals Company Detail
Table 77. Intercept Pharmaceuticals Business Overview
Table 78. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product
Table 79. Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 80. Intercept Pharmaceuticals Recent Development
Table 81. AbbVie Inc. Company Detail
Table 82. AbbVie Inc. Business Overview
Table 83. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Product
Table 84. AbbVie Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 85. AbbVie Inc. Recent Development
Table 86. Madrigal Pharmaceuticals Company Detail
Table 87. Madrigal Pharmaceuticals Business Overview
Table 88. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product
Table 89. Madrigal Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 90. Madrigal Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Alcoholic Steatohepatitis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Global Non-Alcoholic Steatohepatitis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Non-Alcoholic Steatohepatitis Treatment Report Years Considered
Figure 11. Global Non-Alcoholic Steatohepatitis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Non-Alcoholic Steatohepatitis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Players in 2022
Figure 15. Global Top Non-Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue in 2022
Figure 17. North America Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2033)
Figure 19. United States Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2033)
Figure 23. Germany Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2018-2033)
Figure 31. China Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Gilead Sciences Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 46. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 47. Novo Nordisk A/S Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 48. NGM Biopharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 49. Galectin Therapeutics Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 50. Inventiva Pharma Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 51. Intercept Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 52. AbbVie Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 53. Madrigal Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed